Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis

Experimental Parasitology

Volumn 136, Issue 1, 2014, Pages 27-34

  de Mello, Tatiane F P ^a   Bitencourt, Heriberto R ^b   Pedroso, Raissa B ^a   Aristides, Sandra M A ^a   Lonardoni, Maria V C ^a   Silveira, Thais G V ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Antiprotozoal; Chalcones; Cutaneous leishmaniasis; Leishmania braziliensis; Macrophages

Indexed keywords

1 (4 METHOXY PHENYL) 3 (3,4,5 TRIMETHOXY PHENYL)PROP 2 EN 1 ONE; 1 PHENYL 3 (3,4,5 TRIMETHOXY PHENYL) PROP 2 EN 1 ONE; 1,5 BIS(3,4,5 TRIMETHOXY PHENYL) PENTA 1,4 DIEN 3 ONE; 1,5 BIS(PHENYL) PENTA 1,4 DIEN 3 ONE; AMPHOTERICIN B; CHALCONE DERIVATIVE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANTILEISHMANICIDAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHROCYTE; HEMOLYSIS; IN VITRO STUDY; LEISHMANIA BRAZILIENSIS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS;

EID: 84889671317     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2013.11.003     Document Type: Article

References (40)

1. Almeida O.L.S., Santos J.B. Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review. An. Bras. Dermatol. 2011, 86:497-506.
2. Andrighetti-Fröhner C.R., Oliveira K.N., Gaspar-Silva D., Pacheco L.K., Joussef A.C., Steindel M., Simões C.M.O., Souza A.M.T., Magalhães U.O., Afonso I.F., Rodrigues C.R., Nunes R.J., Castro H.C. Synthesis, biological evaluation and SAR of sulfonamide 4-methoxychalcone derivatives with potential antileishmanial activity. Eur. J. Med. Chem. 2009, 44:755-763.
3. Aponte J.C., Castillo D., Estevez Y., Gonzalez G., Arevalo J., Hammond G.B., Sauvain M. In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones. Bioorg. Med. Chem. Lett. 2010, 20:100-103.
4. Bello M.L., Chiaradia L.D., Dias L.R.S., Pacheco L.K., Stumpf T.S., Mascarello A., Steindel M., Yunes R.A., Castro H.C., Nunes R.J., Rodrigues C.R. Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure-activity relationship (SAR). Bioorg. Med. Chem. 2011, 19:5046-5052.
5. Bitencourt H.R., Santos L.S., Souza Filho A.P.S. Atividade Alelopática de chalcona Sintética, de seus Precursores e de Cetonas e Aldeídos Relacionados. Planta Daninha 2007, 25:747-753.
6. Boeck P., Falcão C.A.B., Leal P.C., Yunes R.A., Filho V.C., Torres-Santos E.C., Rossi-Bergmann B. Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg. Med. Chem. 2006, 14:1538-1545.
7. Campos M.B., Gomes C.M.C., Souza A.A.A., Lainson R., Corbett C.E.P., Silveira F.T. In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis. Parasitol. Res. 2008, 103:771-776.
8. Carvalho P.S., Sallum L.O., Cidade A.F., Aquino G.L.B., Napolitano H.B. (E)-1-(4-Methoxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one. Acta Crystallogr. Sect. E Struct. Rep. Online 2011, 10.1107/S1600536811028984.
9. Chen M., Christensen S.B., Theander T.G., Lemmich E., Nadelmann L., Fich K., Theander T.G., Kharazmi A. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob. Agents Chemother. 1993, 37:2550-2556.
10. Chen M., Christensen S.B., Theander T.G., Kharazmi A. Antileishmanial activity of Licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrob. Agents Chemother. 1994, 38:1339-1344.
11. Chen M., Zhai L., Christensen S.B., Theander T.G., Kharazmi A. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob. Agents Chemother. 2001, 45:2023-2029.
12. Coimbra E.S., Antinarelli L.M.R., Silva A.D., Bispo M.L.F., Kaiser C.R., Souza M.V.N. 7-chloro-4-quinolinylhydrazones: a promising and potent class of antileishmanial compounds. Chem. Biol. Drug Des. 2013, 10.1111/cbdd.12112.
13. Ferreira V.F., Jorqueira A., Souza A.M.T., Silva M.N., Souza M.C.B.V., Gouvêa R.M., Rodrigues C.R., Pinto A.V., Castro H.C., Santos D.O., Araújo H.P., Bourguignon S.C. Trypanocidal agents with low cytotoxicity to mammalian cell line: a comparison of the theoretical and biological features of lapachone derivatives. Bioorg. Med. Chem. 2006, 14:5459-5466.
14. Foroumadi A., Emami S., Sorkhi M., Nakhjiri M., Nazarian Z., Heydari S., Ardestani S.K., Poorrajab F., Shafiee A. Chromene-based synthetic chalcones as potent antileishmanial agents: synthesis and biological activity. Chem. Biol. Drug Des. 2010, 75:590-596.
15. Franco L.L., Almeida M.V., Rocha Silva L.F., Vieira P.P.R, Pohlit A.M., Valle M.S. Synthesis and antimalarial activity of dihydroperoxides and tetraoxanes conjugated with bis(benzyl)acetone derivatives. Chem. Biol. Drug Des. 2012, 10.1111/j.1747-0285.2012.01345.x.
16. Green S.G., Meltzer N.S., Hibbs J.B., Nancy C.A. Activated macrophage destroys intracellular Leishmania major amastigotes by an l-arginine dependent killing mechanism. J. Immunol. 1990, 144:278-283.
17. Hermoso A., Jiménez I.A., Mamani Z.A., Bazzocchi I.L., Piñero J.E., Ravelo A.G., Valladares B. Antileishmanial activities of dihydrochalcones from Piper elongatum and synthetic related compounds. structural requirements for activity. Bioorg. Med. Chem. 2003, 11:3975-3980.
18. Honda P.A., Ferreira I.C.P., Cortez D.A.G., Amado C.A.B., Silveira T.G.V., Brenzan M.A., Lonardoni M.V.C. Efficacy of components from leaves of Calophyllum brasiliense against Leishmania (Leishmania) amazonensis. Phytomedicine 2010, 17:333-338.
19. Hussain T., Siddiqui H.L., Zia-ur-Rehman M., Yasinzai M.M., Parvez M. Anti-oxidant, anti-fungal and anti-leishmanial activities of novel 3-[4-(1H-imidazol-1-yl) phenyl] prop-2-en-1-ones. Eur. J. Med. Chem. 2009, 44:4654-4660.
20. Kamal A., Reddy M.K., Arutla V. The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs. Expert Opin. Drug Discov. 2013, 10.1517/17460441.2013.758630.
21. Liew F.Y., Li Y., Moss D., Parkinson C., Rogers M.V., Moncada S. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 1991, 21:3009-3014.
22. Liu M., Wilairat P., Croft S.L., Tan A.L.C., Go M.L. Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg. Med. Chem. 2003, 11:2729-2738.
23. Liu X.L., Xu Y.J., Go M.L. Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus. Eur. J. Med. Chem. 2008, 43:1681-1687.
24. Lunardi F., Guzela M., Rodrigues A.T., Corrêa R., Eger-Mangrich I., Steindel M., Grisard E.C., Assreuy J., Calixto J.B., Santos A.R.S. Trypanocidal and leishmanicidal properties of substitution-containing chalcones. Antimicrob. Agents Chemother. 2003, 47:1449-1451.
25. Piñero J., Temporal R.M., Goncalves A.J.S., Jiménez I.A., Bazzocchi I.L., Oliva A., Perera A., Leon L.L., Valladares B. New administration model of trans-chalcone biodegradable polymers for the treatment of experimental leishmaniasis. Acta Trop. 2006, 98:59-65.
26. Rojas J., Payá M., Dominguez J.N., Ferrándiz M.L. The synthesis and effect of fluorinated chalcone derivatives on nitric oxide production. Bioorg. Med. Chem. Lett. 2002, 12:1951-1954.
27. Salem M.M., Werbovetz K.A. Antiprotozoal compounds from Psorothamnus polydenius. J. Nat. Prod. 2005, 68:108-111.
28. Santos D.O., Coutinho C.E.R., Madeira M.F., Bottino C.G., Vieira R.T., Nascimento S.B., Bernardino A., Bourguignon S.C., Corte-Real S., Pinho R.T., Rodrigues C.R., Castro H.C. Leishmaniasis treatment - a challenge that remains: a review. Parasitol. Res. 2008, 103:1-10.
29. Saxena H.O., Faridi U., Kumar J.K., Luqman S., Darokar M.P., Shanker K., Chanotiya C.S., Gupta M.M., Negi A.S. Synthesis of chalcone derivatives on steroidal framework and their anticancer activities. Steroids 2007, 72:892-900.
30. Shin H.J., Shon D.H., Youn H.S. Isobavachalcone suppresses expression of inducible nitric oxide synthase induced by Toll-like receptor agonists. Int. Immunopharmacol. 2013, 15:38-41.
31. Singh N., Kumar M., Singh R.K. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac. J. Trop. Med. 2012, 485-497.
32. Souza A.M.T., Castro H.C., Brito M.A., Andrighetti-Fröhner C.R., Magalhães U., Oliveira K.N., Gaspar-Silva D., Pacheco L.K., Joussef A.C., Steindel M., Simões C.M.O., Santos D.O., Albuquerque M.G., Rodrigues C.R., Nunes R.J. Leishmania amazonensis growth inhibitors: biological and theoretical features of sulfonamide 4-methoxychalcone derivatives. Curr. Microb. 2009, 59:374-379.
33. Souza A.S., Giudice A., Pereira J.M.B., Guimarães L.H., Jesus A.R., Moura T.R., Wilson M.E., Carvalho E.M., Almeida R.P. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-α production. BMC Infect. Dis. 2010, 10:209.
34. Torres-Santos E.C., Moreira D.L., Kaplan M.A.C., Meirelles M.A., Rossi-Bergmann B. Selective effect of 2',6'-dihidroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob. Agents Chemother. 1999, 43:1234-1241.
35. Torres-Santos E.C., Sampaio-Santos M.I., Buckner F.S., Yokoyama K., Gelb M., Urbina J.A., Rossi-Bergmann B. Altered sterol profile induced in Leishmania amazonensis by a natural dihydroxymethoxylated chalcone. J. Antimicrob. Chemother. 2009, 63:469-472.
36. Valdez R.H., Tonin L.T.D., Ueda-Nakamura T., Filho B.P.D., Morgado-Diaz J.A., Sarragiotto M.H., Nakamura C.V. Biological activity of 1,2,3,4-tetrahydro-β-carboline-3-carboxamides against Trypanosoma cruzi. Acta Trop. 2009, 110:7-14.
37. World Health Organization Technical Report Series 949- Control of Leishmaniasis http://new.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=16971&Itemid=Last accessed 5 December 2010.
38. World Health Organization Burden of disease: Leishmaniasis http://who.int/leishmaniasis/burden/en/. Last accessed 21 January 2013.
39. Zhai L., Blom J., Chen M., Christensen S.B., Kharazmi A. The antileishmanial agent licochalcone a interferes with the function of parasite mitochondria. Antimicrob. Agents Chemother. 1995, 39:2742-2748.
40. Zhai L., Chen M., Blom J., Theander T.G., Christensen S.B., Kharazmi A. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J. Antimicrob. Chemother. 1999, 43:793-803.